Cited by 376RNA and protein synthesis mechanismsPI3K/AKT/mTOR signaling in cancerRNA modifications and cancer

The DOI matches its Crossref record; 220 of the 227 references it cites were found in a registry or an index.

Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development

Open access

Pelletier, Jerry, Graff, Jeremy, Ruggero, Davide, Sonenberg, Nahum·2015·Cancer Research

DOI 10.1158/0008-5472.can-14-2789PMC PMC4299928

Open this paper in CoChat — free account

Abstract

Elevated protein synthesis is an important feature of many cancer cells and often arises as a consequence of increased signaling flux channeled to eukaryotic initiation factor 4F (eIF4F), the key regulator of the mRNA–ribosome recruitment phase of translation initiation. In many cellular and preclinical models of cancer, eIF4F deregulation results in changes in translational efficiency of specific mRNA classes. Importantly, many of these mRNAs code for proteins that potently regulate critical cellular processes, such as cell growth and proliferation, enhanced cell survival and cell migration that ultimately impinge on several hallmarks of cancer, including increased angiogenesis, deregulated growth control, enhanced cellular survival, epithelial-to-mesenchymal transition, invasion, and metastasis. By being positioned as the molecular nexus downstream of key oncogenic signaling pathways (e.g., Ras, PI3K/AKT/TOR, and MYC), eIF4F serves as a direct link between important steps in cancer development and translation initiation. Identification of mRNAs particularly responsive to elevated eIF4F activity that typifies tumorigenesis underscores the critical role of eIF4F in cancer and raises the exciting possibility of developing new-in-class small molecules targeting translation initiation as antineoplastic agents. Cancer Res; 75(2); 250–63. ©2014 AACR.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-14-2789

Cites

220 of 220 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

Fibroblast growth factor-2 induces translational regulation of Bcl-XL and Bcl-2 via a MEK-dependent pathway. CORRELATION WITH RESISTANCE TO ETOPOSIDE-INDUCED APOPTOSIS.
Pardo, O. E., Arcaro, A., Salerno, G., Raguz, S., Downward, J., & Seckl, M. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.a115.109006 · Cited by 153
Retracted
Fibroblast Growth Factor-2 Induces Translational Regulation of Bcl-XL and Bcl-2 via a MEK-dependent Pathway
Pardo, O. E., Arcaro, A., Salerno, G., Raguz, S., Downward, J., & Seckl, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109006200 · Cited by 145
Retracted
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Molecular mechanisms of mTOR-mediated translational control
Ma, X. M., & Blenis, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2672 · Cited by 2,558
eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation
Gingras, A., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,103
Self-citation
A unifying model for mTORC1-mediated regulation of mRNA translation
Thoreen, C. C., Chantranupong, L., Keys, H. R., Wang, T., Gray, N. S., & Sabatini, D. M. (2012) · Nature · doi:10.1038/nature11083 · Cited by 1,477
Regulation of 4E-BP1 phosphorylation: a novel two-step mechanismPreprint
Gingras, A., Gygi, S. P., Raught, B., Polakiewicz, R. D., Abraham, R. T., Hoekstra, M. F., Aebersold, R. H., & Sonenberg, N. (1999) · Genes & Development · doi:10.1101/gad.13.11.1422 · Cited by 1,348
Self-citation
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Hsieh, A. C., Liu, Y., Edlind, M. P., Ingolia, N. T., Janes, M. R., Sher, A., Shi, E. Y., Stumpf, C. R., Christensen, C., Bonham, M. J., et al. (2012) · Nature · doi:10.1038/nature10912 · Cited by 1,313
Self-citation
Phosphorylation and Functional Inactivation of TSC2 by Erk
Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., & Pandolfi, P. P. (2005) · Cell · doi:10.1016/j.cell.2005.02.031 · Cited by 1,268

Show all 227 references

Sorted by citations

Items 101–200 of 376

Ribosome Shunting, Polycistronic Translation, and Evasion of Antiviral Defenses in Plant Pararetroviruses and Beyond
Pooggin, M. M., & Ryabova, L. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00644 · Cited by 43
Therapeutic Opportunities in Eukaryotic TranslationPreprint
Chu, J., & Pelletier, J. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a032995 · Cited by 40
Self-citation
Concise Synthesis of a Pateamine A Analogue with In Vivo Anticancer Activity Based on an Iron‐Catalyzed Pyrone Ring Opening/Cross‐Coupling
Zhuo, C., & Fürstner, A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201602125 · Cited by 41
MYC’s Fine Line Between B Cell Development and Malignancy
de Barrios, O., Meler, A., & Parra, M. (2020) · Cells · doi:10.3390/cells9020523 · Cited by 46
eIF4E S209 phosphorylation licenses myc- and stress-driven oncogenesis
Ruan, H., Li, X., Xu, X. M., Leibowitz, B. J., Tong, J., Chen, L., Ao, L., Xing, W., Luo, J., Yu, Y., et al. (2020) · eLife · doi:10.7554/elife.60151 · Cited by 41
Self-citation
Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
Singh, K., Lin, J., Lecomte, N., Mohan, P., Gokce, A., Sanghvi, V. R., Jiang, M., Grbovic-Huezo, O., Burčul, A., Stark, S. G., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2929 · Cited by 39
Synthesis of Fluorophosphate Nucleotide Analogues and Their Characterization as Tools for 19F NMR Studies
Baranowski, M. R., Nowicka, A. M., Rydzik, A. M., Warmiński, M., Kasprzyk, R., Wojtczak, B. A., Wójcik, J., Claridge, T. D. W., Kowalska, J., & Jemielity, J. (2015) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.5b00337 · Cited by 39
Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1
Wang, J., Ye, Q., Cao, Y., Guo, Y., Huang, X., Mi, W., Liu, S., Wang, C., Yang, H., Zhou, B. P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02243-3 · Cited by 38
Nutrient Control of mRNA Translation
Shu, X. E., Swanda, R. V., & Qian, S. (2020) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-120919-041411 · Cited by 39
RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer
Cuesta, R., & Holz, M. K. (2016) · Oncotarget · doi:10.18632/oncotarget.8375 · Cited by 37
The mTORC1/4E-BP/eIF4E Axis Promotes Antibody Class Switching in B Lymphocytes
Chiu, H., Jackson, L. V., Oh, K. I., Mai, A., Ronai, Z. A., Ruggero, D., & Fruman, D. A. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800602 · Cited by 39
Self-citation
Chemical Synthesis Enables Structural Reengineering of Aglaroxin C Leading to Inhibition Bias for Hepatitis C Viral Infection
Zhang, W., Liu, S., Maïga, R. I., Pelletier, J., Brown, L. E., Wang, T. T., & Porco, J. A. J. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b11477 · Cited by 34
Self-citation
RNA-binding protein DDX1 is responsible for fatty acid-mediated repression of insulin translation
Li, Z., Zhou, M., Cai, Z., Liu, H., Zhong, W., Hao, Q., Cheng, D., Hu, X. S., Hou, J., Xu, P., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky867 · Cited by 34
Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas
Zhang, X., Bi, C., Lu, T., Zhang, W., Yue, T., Wang, C., Tian, T., Zhang, X., Huang, Y., Lunning, M. A., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0503-z · Cited by 34
Targeting Protein Synthesis in Colorectal Cancer
Schmidt, S., Denk, S., & Wiegering, A. (2020) · Cancers · doi:10.3390/cancers12051298 · Cited by 36
Galeterone and The Next Generation Galeterone Analogs, VNPP414 and VNPP433-3β Exert Potent Therapeutic Effects in Castration-/Drug-Resistant Prostate Cancer Preclinical Models In Vitro and In Vivo
Kwegyir‐Afful, A. K., Ramalingam, S., Ramamurthy, V. P., Purushottamachar, P., Murigi, F. N., Vasaitis, T. S., Huang, W., Kane, M. A., Zhang, Y., Ambulos, N. P., et al. (2019) · Cancers · doi:10.3390/cancers11111637 · Cited by 34
Comparative phytochemistry of flavaglines (= rocaglamides), a group of highly bioactive flavolignans from Aglaia species (Meliaceae)
Greger, H. (2021) · Phytochemistry Reviews · doi:10.1007/s11101-021-09761-5 · Cited by 33
Translation Inhibitors Activate Autophagy Master Regulators TFEB and TFE3
Dang, T. T., & Back, S. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112083 · Cited by 33
NF-κB/mTOR/MYC Axis Drives PRMT5 Protein Induction After T Cell Activation via Transcriptional and Non-transcriptional Mechanisms
Webb, L., Miranda, J. N., Amici, S. A., Sengupta, S., Nagy, G., & Guerau‐de‐Arellano, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00524 · Cited by 31
Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication
Zhou, X., Xu, L., Wang, Y., Wang, W., Sprengers, D., Metselaar, H. J., Peppelenbosch, M. P., & Pan, Q. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.10.016 · Cited by 31
Identification of Cardiac Glycosides as Novel Inhibitors of eIF4A1-Mediated Translation in Triple-Negative Breast Cancer Cells
Howard, C. M., Estrada, M. D., Terrero, D., Tiwari, A. K., & Raman, D. (2020) · Cancers · doi:10.3390/cancers12082169 · Cited by 31
CXCR7 promotes melanoma tumorigenesis via Src kinase signaling
Xu, S., Tang, J., Wang, C., Liu, J., Fu, Y., & Luo, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1442-3 · Cited by 32
AEG ‐1 induces gastric cancer metastasis by upregulation of eIF 4E expression
Wu, S., Yang, L., Wu, D., Gao, Z., Li, P., Huang, W., & Wang, X. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13258 · Cited by 29
The Novel Mnk1/2 Degrader and Apoptosis Inducer VNLG-152 Potently Inhibits TNBC Tumor Growth and Metastasis
Ramalingam, S., Ramamurthy, V. P., Gediya, L. K., Murigi, F. N., Purushottamachar, P., Huang, W., Choi, E. Y., Zhang, Y., Vasaitis, T. S., Kane, M. A., et al. (2019) · Cancers · doi:10.3390/cancers11030299 · Cited by 28
In-Depth Characterization of Apoptosis N-Terminome Reveals a Link Between Caspase-3 Cleavage and Posttranslational N-Terminal Acetylation
Hanna, R., Rozenberg, A., Saied, L., Ben-Yosef, D., Lavy, T., & Kleifeld, O. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100584 · Cited by 28
Anti-Cancer Effect of Cap-Translation Inhibitor 4EGI-1 in Human Glioma U87 Cells: Involvement of Mitochondrial Dysfunction and ER Stress
Wu, M., Zhang, C., Li, X., Liu, Q., & Wanggou, S. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000453158 · Cited by 28
Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas
Schwartz, H., Scroggins, B., Zuehlke, A. D., Kijima, T., Beebe, K. E., Mishra, A., Neckers, L., & Prince, T. L. (2015) · Cell Stress and Chaperones · doi:10.1007/s12192-015-0604-1 · Cited by 27
piRNA PROPER Suppresses DUSP1 Translation by Targeting N 6 ‐Methyladenosine‐Mediated RNA Circularization to Promote Oncogenesis of Prostate Cancer
Ben, S., Ding, Z., Xin, J., Li, F., Cheng, Y., Chen, S., Fan, L., Zhang, Q., Li, S., Du, M., et al. (2024) · Advanced Science · doi:10.1002/advs.202402954 · Cited by 26
Anchimerically Activated ProTides as Inhibitors of Cap-Dependent Translation and Inducers of Chemosensitization in Mantle Cell Lymphoma
Okon, A. M., Han, J., Dawadi, S., Demosthenous, C., Aldrich, C. C., Gupta, M., & Wagner, C. R. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00916 · Cited by 26
cat-ELCCA: catalyzing drug discovery through click chemistry
Garner, A. L. (2018) · Chemical Communications · doi:10.1039/c8cc02332h · Cited by 26
Prosurvival IL-7–Stimulated Weak Strength of mTORC1-S6K Controls T Cell Memory via Transcriptional FOXO1–TCF1–Id3 and Metabolic AMPKα1–ULK1–ATG7 Pathways
Xu, A., Leary, S. C., Islam, M. F., Wu, Z., Bhanumathy, K. K., Ara, A., Chibbar, R., Fleywald, A., Ahmed, K. A., & Xiang, J. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100452 · Cited by 27
Enhanced Antitumor Activity of an Anti-5T4 Antibody–Drug Conjugate in Combination with PI3K/mTOR inhibitors or Taxanes
Shor, B., Kahler, J., Dougher, M. M., Xu, J. J., Mack, M. L., Rosfjord, E. C., Wang, F., Melamud, E., & Sapra, P. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1166 · Cited by 28
Transcription Factors in Breast Cancer—Lessons From Recent Genomic Analyses and Therapeutic Implications
Zacksenhaus, E., Liu, J.-K., Jiang, Z., Yao, Y., Xia, L., Shrestha, M., & Ben‐David, Y. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2016.10.003 · Cited by 28
eIF2α Phosphorylation Mediates IL24-Induced Apoptosis through Inhibition of Translation
Persaud, L., Zhong, X., Alvarado, G., Do, W., Dejoie, J., Zybtseva, A., Aktas, B. H., & Sauane, M. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0454 · Cited by 27
Impact of FHIT loss on the translation of cancer-associated mRNAs
Kiss, D., Baez, W., Huebner, K., Bundschuh, R. A., & Schoenberg, D. R. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0749-x · Cited by 26
eIF4B is a convergent target and critical effector of oncogenic Pim and PI3K/Akt/mTOR signaling pathways in Abl transformants
Chen, K., Yang, J., Li, J., Wang, X., Chen, Y., Huang, S., & Chen, J. (2016) · Oncotarget · doi:10.18632/oncotarget.7164 · Cited by 26
Downregulation of the protein synthesis machinery is a major regulatory event during early adipogenic differentiation of human adipose-derived stromal cells
Marcon, B. H., Holetz, F., Eastman, G., Origa-Alves, A. C., Amorós, M., de Aguiar, A. M., Rebelatto, C. L. K., Brofman, P. R. S., Sotelo-Silveira, J. R., & Dallagiovanna, B. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.10.027 · Cited by 26
Structural insights reveal a recognition feature for tailoring hydrocarbon stapled-peptides against the eukaryotic translation initiation factor 4E protein
Lama, D., Liberatore, A., Frosi, Y., Nakhlé, J., Tsomaia, N., Bashir, T., Lane, D. P., Brown, C. J., Verma, C. S., & Auvin, S. (2019) · Chemical Science · doi:10.1039/c8sc03759k · Cited by 25
The CXCR4-LASP1-eIF4F Axis Promotes Translation of Oncogenic Proteins in Triple-Negative Breast Cancer Cells
Howard, C. M., Bearss, N. R., Subramaniyan, B., Tilley, A. M. C., Sridharan, S., Villa, N., Fraser, C. S., & Raman, D. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00284 · Cited by 25
By reducing global mRNA translation in several ways, 2-deoxyglucose lowers MCL-1 protein and sensitizes hemopoietic tumor cells to BH3 mimetic ABT737
Tailler, M., Lindqvist, L., Gibson, L., & Adams, J. M. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0244-y · Cited by 22
mRNA- and factor-driven dynamic variability controls eIF4F-cap recognition for translation initiation
Çetin, B., & O’Leary, S. E. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac631 · Cited by 20
Novel eIF4A1 inhibitors with anti‐tumor activity in lymphoma
Kayastha, F. B., Herrington, N. B., Kapadia, B. B., Roychowdhury, A., Nanaji, N. M., Kellogg, G. E., & Gartenhaus, R. B. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00534-0 · Cited by 24
EIF4G1 Is a Potential Prognostic Biomarker of Breast Cancer
Li, K., Tan, G., Zhang, X., Lu, W., Ren, J., Si, Y., Adu‐Gyamfi, E. A., Li, F., Wang, Y., Xie, B., et al. (2022) · Biomolecules · doi:10.3390/biom12121756 · Cited by 23
Consideration of Binding Kinetics in the Design of Stapled Peptide Mimics of the Disordered Proteins Eukaryotic Translation Initiation Factor 4E-Binding Protein 1 and Eukaryotic Translation Initiation Factor 4G
Gallagher, E. E., Song, J. M., Menon, A., Mishra, L. D., Chmiel, A. F., & Garner, A. L. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00068 · Cited by 24
Cell Fate Control by Translation: mRNA Translation Initiation as a Therapeutic Target for Cancer Development and Stem Cell Fate Control
Kim, H. (2019) · Biomolecules · doi:10.3390/biom9110665 · Cited by 24
Design of Cell-Permeable Inhibitors of Eukaryotic Translation Initiation Factor 4E (eIF4E) for Inhibiting Aberrant Cap-Dependent Translation in Cancer
Cárdenas, E. L., O’Rourke, R. L., Menon, A., Meagher, J. L., Stuckey, J. A., & Garner, A. L. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00917 · Cited by 22
Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1α levels under hypoxia
Glück, A. A., Orlando, E., Leiser, D., Turan, M. P., Nisa, L., Quintin, A., Gavini, J., Stroka, D., Berezowska, S., Bubendorf, L., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0256-6 · Cited by 22
mRNA Recruiting eIF4 Factors Involved in Protein Synthesis and Its Regulation
Mishra, R. K., Datey, A., & Hussain, T. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00788 · Cited by 23
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer
Nardi, F., Perurena, N., Schade, A. E., Li, Z.-H., Ngo, K., Ivanova, E. V., Saldanha, A., Li, C., Gokhale, P. C., Hata, A. N., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci167651 · Cited by 21
“However, the translational control of these targets by eIF4A appears to be very tumor-type specific (11, 15).”
Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation
Marcus, H., Attar‐Schneider, O., Dabbah, M., Zismanov, V., Tartakover‐Matalon, S., Lishner, M., & Drucker, L. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.03.003 · Cited by 21
Targeting eIF4F translation initiation complex with SBI-756 sensitises B lymphoma cells to venetoclax
Herzog, L.-O., Walters, B., Buono, R., Lee, J. S., Mallya, S., Fung, A., Chiu, H., Nguyen, N., Li, B., Pinkerton, A. B., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01205-9 · Cited by 21
Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design
Han, W., Ding, Y., Xu, Y., Pfister, K. B., Zhu, S., Warne, B., Doyle, M., Aikawa, M., Amiri, P., Appleton, B. A., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01657 · Cited by 21
Discovery of Novel Small Molecule Inhibitors of VEGF Expression in Tumor Cells Using a Cell-Based High Throughput Screening Platform
Cao, L., Weetall, M. L., Bombard, J., Qi, H., Arasu, T., Lennox, W., Hedrick, J., Sheedy, J., Risher, N., Brooks, P. C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168366 · Cited by 22
Oncogenic MNK signalling regulates the metastasis suppressor NDRG1
Tian, S., Wang, X., & Proud, C. G. (2017) · Oncotarget · doi:10.18632/oncotarget.17555 · Cited by 21
Deciphering the mechanistic effects of eIF4E phosphorylation on mRNA‐cap recognition
Lama, D., & Verma, C. S. (2019) · Protein Science · doi:10.1002/pro.3798 · Cited by 21
Integrative Modeling Identifies Key Determinants of Inhibitor Sensitivity in Breast Cancer Cell Lines
Jastrzebski, K., Thijssen, B., Kluin, R. J. C., de Lint, K., Majewski, I. J., Beijersbergen, R. L., & Wessels, L. F. A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2698 · Cited by 21
Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells
Ju, Y., Ben‐David, Y., Rotin, D., & Zacksenhaus, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-88816-1 · Cited by 20
KSR1- and ERK-dependent translational regulation of the epithelial-to-mesenchymal transition
Rao, C., Frodyma, D. E., Southekal, S., Svoboda, R. A., Black, A. R., Guda, C., Mizutani, T., Clevers, H. C., Johnson, K. R., Fisher, K. W., et al. (2021) · eLife · doi:10.7554/elife.66608 · Cited by 22
Concise Synthesis of a Pateamine A Analogue with In Vivo Anticancer Activity Based on an Iron‐Catalyzed Pyrone Ring Opening/Cross‐Coupling
Zhuo, C., & Fürstner, A. (2016) · Angewandte Chemie · doi:10.1002/ange.201602125 · Cited by 20
Phosphoproteomics of colon cancer metastasis: comparative mass spectrometric analysis of the isogenic primary and metastatic cell lines SW480 and SW620
Schunter, A. J., Yue, X. S., & Hummon, A. B. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-0125-5 · Cited by 21
Cancer as an ecomolecular disease and a neoplastic consortium
y Cajal, S. R., Capdevila, C., Hernández‐Losa, J., Mattos‐Arruda, L. D., Ghosh, A., Lorent, J., Larsson, O. S., Aasen, T., Postovit, L.-M. M., & Topisirović, I. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.09.004 · Cited by 20
eIF4A inhibition prevents the onset of cytokine-induced muscle wasting by blocking the STAT3 and iNOS pathways
Cramer, Z., Sadek, J., Galicia-Vázquez, G., Marco, S. D., Pause, A., Pelletier, J., & Gallouzi, I. (2018) · Scientific Reports · doi:10.1038/s41598-018-26625-9 · Cited by 19
Self-citation
The pattern of expression and prognostic value of key regulators for m7G RNA methylation in hepatocellular carcinoma
Chen, J., Yao, S., Sun, Z., Wang, Y., Yue, J., Cui, Y., Yu, C., Xu, H., & Li, L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.894325 · Cited by 19
Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation
Dabbah, M., Attar‐Schneider, O., Zismanov, V., Matalon, S. T., Lishner, M., & Drucker, L. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1115-510rr · Cited by 19
A cell-penetrant lactam-stapled peptide for targeting eIF4E protein-protein interactions
Gallagher, E. E., Menon, A., Chmiel, A. F., Deprey, K. L., Kritzer, J. A., & Garner, A. L. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112655 · Cited by 19
Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules
Fanunza, E., Frau, A., Corona, A., & Tramontano, E. (2018) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2018.08.004 · Cited by 20
Translational Regulation by eIFs and RNA Modifications in Cancer
Zhang, L., Zhang, Y., Zhang, S., Qiu, L., Zhang, Y., Zhou, Y., Han, J., & Xie, J. (2022) · Genes · doi:10.3390/genes13112050 · Cited by 18
Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas
Roller, D. G., Capaldo, B. J., Bekiranov, S., Mackey, A. J., Conaway, M. R., Petricoin, E. F., Gioeli, D. G., & Weber, M. J. (2015) · Oncotarget · doi:10.18632/oncotarget.6548 · Cited by 18
It’s Not the Destination, It’s the Journey: Heterogeneity in mRNA Export Mechanisms
Scott, D. D., Aguilar, L. C., Kramar, M., & Oeffinger, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-31434-7_2 · Cited by 19
Translation initiation and its relevance in colorectal cancer
Minnee, E., & Faller, W. J. (2020) · FEBS Journal · doi:10.1111/febs.15690 · Cited by 20
Efficacy of a Novel Bi-Steric mTORC1 Inhibitor in Models of B-Cell Acute Lymphoblastic Leukemia
Lee, B. J., Mallya, S., Dinglasan, N., Fung, A., Nguyen, T., Herzog, L.-O., Thao, J., Lorenzana, E. G., Wildes, D. P., Singh, M., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.673213 · Cited by 18
Induction of the p53 Tumor Suppressor in Cancer Cells through Inhibition of Cap-Dependent Translation
Harris, B., Wang, D., Zhang, Y., Ferrari, M. G., Okon, A. M., Cleary, M. P., Wagner, C. R., & Yang, D. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00367-17 · Cited by 18
Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma
Mittenbühler, M. J., Sprenger, H.-G., Gruber, S., Wunderlich, C. M., Kern, L., Brüning, J. C., & Wunderlich, F. T. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.08.010 · Cited by 18
Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation
Champagne, J., Nielsen, M. M., Feng, X., Navarro, J. M., Pataskar, A., Voogd, R., Giebel, L., Nagel, R., Berenst, N., Fumagalli, A., et al. (2025) · Immunity · doi:10.1016/j.immuni.2024.12.004 · Cited by 17
EGPI-1, a novel eIF4E/eIF4G interaction inhibitor, inhibits lung cancer cell growth and angiogenesis through Ras/MNK/ERK/eIF4E signaling pathway
Qi, X., Zhang, S., Chen, Z., Wang, L., Zhu, W., Yin, C., Fan, J., Wu, X., Wang, J., & Guo, C. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109773 · Cited by 17
Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinoma
Lauer, S. M., Omar, M. H., Golkowski, M. G., Kenerson, H. L., Lee, K., Pascual, B. C., Lim, H. C., Forbush, K. A., Smith, F. D., Gordan, J. D., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113678 · Cited by 17
High-Throughput Chemical Probing of Full-Length Protein–Protein Interactions
Song, J. M., Menon, A., Mitchell, D. C., Johnson, O. T., & Garner, A. L. (2017) · ACS Combinatorial Science · doi:10.1021/acscombsci.7b00128 · Cited by 18
Relaxed initiation pausing of ribosomes drives oncogenic translation
Dong, L., Mao, Y., Zhou, A., Liu, X., Zhou, J. L., Wan, J., & Qian, S. (2021) · Science Advances · doi:10.1126/sciadv.abd6927 · Cited by 18
Targeting mTOR and eIF4E: a feasible scenario in ovarian cancer therapy
Romagnoli, A., Maracci, C., D’Agostino, M., Teana, A. L., & Marino, D. D. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2021.20 · Cited by 18
Translational Control of Metabolism and Cell Cycle Progression in Hepatocellular Carcinoma
Scagliola, A., Miluzio, A., & Biffo, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054885 · Cited by 17
4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma
De, A., Jacobson, B. A., Peterson, M. S., Jay-Dixon, J., Kratzke, M. G., Sadiq, A. A., Patel, M. R., & Kratzke, R. A. (2017) · Investigational New Drugs · doi:10.1007/s10637-017-0535-z · Cited by 16
The role of olefin geometry in the activity of hydrocarbon stapled peptides targeting eukaryotic translation initiation factor 4E (eIF4E)
Song, J. M., Gallagher, E. E., Menon, A., Mishra, L. D., & Garner, A. L. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob01041f · Cited by 16
Recent advances of molecular mechanisms of regulating PD-L1 expression in melanoma
Han, J., Xu, X., Liu, Z., Li, Z., Wu, Y., & Zuo, D. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106971 · Cited by 16
Tidy up - The unfolded protein response in sepsis
Vivas, W., & Weis, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.980680 · Cited by 17
Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression
Kiss, D., Waters, C. E., Ouda, I. M., Saldivar, J. C., Karras, J. R., Amin, Z. A., Mahrous, S., Druck, T., Bundschuh, R. A., Schoenberg, D. R., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.01.005 · Cited by 16
Eukaryotic Translation Initiation Factor 4AI: A Potential Novel Target in Neuroblastoma
Skofler, C., Kleinegger, F., Krassnig, S., Birkl-Toeglhofer, A. M., Singer, G., Till, H., Benesch, M., Cencic, R., Porco, J. A. J., Pelletier, J., et al. (2021) · Cells · doi:10.3390/cells10020301 · Cited by 16
Self-citation
Anticancer Effects of I-BET151, an Inhibitor of Bromodomain and Extra-Terminal Domain Proteins
Lai, J., Liu, Z., Zhao, Y., Ma, C., & Huang, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.716830 · Cited by 15
Burkholderia Lethal Factor 1, a Novel Anti-Cancer Toxin, Demonstrates Selective Cytotoxicity in MYCN-Amplified Neuroblastoma Cells
Rust, A., Shah, S. H., Hautbergue, G. M., & Davletov, B. A. (2018) · Toxins · doi:10.3390/toxins10070261 · Cited by 15
Ginkgo biloba induces different gene expression signatures and oncogenic pathways in malignant and non-malignant cells of the liver
Czauderna, C., Domínguez, M. P., Castven, D., Becker, D., Luis, Z., Hajduk, J., Mahn, F. L., Herr, M., Strand, D. J., Strand, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209067 · Cited by 15
Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer
Ruan, H., Leibowitz, B. J., Peng, Y., Shen, L., Chen, L., Kuang, C., Schoen, R. E., Lu, X., Zhang, L., & Yu, J. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00070-7 · Cited by 14
Deciphering the pseudouridine nucleobase modification in human diseases: From molecular mechanisms to clinical perspectives
Jia, S., Yu, X., Deng, N., Chen, Z., Ju, M., Wang, F., Zhang, Y., Gao, Z., Li, Y., Zhou, H., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70190 · Cited by 14
Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma
Paíno, T., González-Méndez, L., San‐Segundo, L., Corchete, L. A., Hernández-García, S., Díaz-Tejedor, A., Algarín, E. M., Mogollón, P., Martín-Sánchez, M., Gutierrez, N. C., et al. (2020) · Cancers · doi:10.3390/cancers12102743 · Cited by 14
Ribavirin inhibits the growth and ascites formation of hepatocellular carcinoma through downregulation of type I CARM1 and type II PRMT5
Tian, Y., Yang, W., Yang, R., Zhang, Q., Hao, L., Bian, E., Yang, Y., Huang, X., Wu, Y., & Zhang, B. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115829 · Cited by 14
Downregulation of Methionine Cycle Genes MAT1A and GNMT Enriches Protein-Associated Translation Process and Worsens Hepatocellular Carcinoma Prognosis
Chen, P., Tsai, C.-H., Huang, C., Hwang, H., Li, J., Liu, C.-C., Ko, H., & Chiang, E. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010481 · Cited by 14
Extracellular arginine availability modulates eIF2α O-GlcNAcylation and heme oxygenase 1 translation for cellular homeostasis
Hung, Y.-W., Ouyang, C., Ping, X., Qi, Y., Wang, Y.-C., Kung, H., & Ann, D. (2023) · Journal of Biomedical Sciences · doi:10.1186/s12929-023-00924-4 · Cited by 12
eIF4F controls ERK MAPK signaling in melanomas with BRAF and NRAS mutations
Valčíková, B., Vadovičová, N., Smolkova, K., Zacpalova, M., Krejčı́, P., Lee, S., Rauch, J., Kölch, W., von Kriegsheim, A., Dorotikova, A., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2321305121 · Cited by 12
The molecular choreography of protein synthesis: translational control, regulation, and pathways
Chen, J., Choi, J., O’Leary, S. E., Prabhakar, A., Petrov, A. N., Grosely, R., Puglisi, E. V., & Puglisi, J. D. (2016) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583516000056 · Cited by 16
FXR1a-associated microRNP: A driver of specialized non-canonical translation in quiescent conditions
Bukhari, S. I. A., & Vasudevan, S. (2016) · RNA Biology · doi:10.1080/15476286.2016.1265197 · Cited by 14
The Importance of Protein Phosphorylation for Signaling and Metabolism in Response to Diel Light Cycling and Nutrient Availability in a Marine Diatom
Tan, M. H., Smith, S. R., Hixson, K. K., Tan, J., McCarthy, J. K., Kustka, A. B., & Allen, A. E. (2020) · Biology · doi:10.3390/biology9070155 · Cited by 13
LINC02870 facilitates SNAIL translation to promote hepatocellular carcinoma progression
Guo, M., Zhuang, H., Huang, J., Shao, X., Bai, N., Li, M., Niu, M., Wei, W., Sun, L., Li, Y., et al. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04575-1 · Cited by 13

Authors: Pelletier, J., Graff, J., Ruggero, D., & Sonenberg, N.
Affiliations: Institut du cancer Rosalind & Morris Goodman (CA)
Eli Lilly (United States) (US)
University of California, San Francisco (US)
Corresponding author: Pelletier, Jerry
ORCID: Pelletier, Jerry
Ruggero, Davide
Sonenberg, Nahum
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2015-01-14
Volume: 75
Issue: 2
Pages: 250-263
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-14-2789
PMC: PMC4299928
OpenAlex: W2005176113
Cited by: 367
References: 227
Citations by year: 2026: 18 · 2025: 18 · 2024: 30 · 2023: 36 · 2022: 30 · 2021: 39 · 2020: 32 · 2019: 35 · 2018: 40 · 2017: 33 · 2016: 37 · 2015: 19
FWCI: 4.17
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
eScholarship@McGill (McGill) (submittedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: U.S. Public Health Service (MOP-106530, MOP-115126)
National Cancer Institute (R01CA140456, R01CA184624, R01CA154916)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
Keywords: eIF4F, translation initiation, cancer, translational regulation, oncogenic signaling, Ras, c-Myc, metastasis, epithelial-mesenchymal transition, angiogenesis, cell proliferation
MeSH terms: Animals, Antineoplastic Agents, Humans, Neoplasms, Eukaryotic Initiation Factor-4F, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks